279 related articles for article (PubMed ID: 14567559)
1. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
Hartrich L; Weinstock-Guttman B; Hall D; Badgett D; Baier M; Patrick K; Feichter J; Hong J; Ramanathan M
J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
[TBL] [Abstract][Full Text] [Related]
3. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.
Ossege LM; Sindern E; Patzold T; Malin JP
Int Immunopharmacol; 2001 Jun; 1(6):1085-100. PubMed ID: 11407304
[TBL] [Abstract][Full Text] [Related]
5. The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.
Zula JA; Green HC; Ransohoff RM; Rudick RA; Stark GR; van Boxel-Dezaire AH
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19689-94. PubMed ID: 22106296
[TBL] [Abstract][Full Text] [Related]
6. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
8. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients.
Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
Eur J Neurol; 2000 Nov; 7(6):647-53. PubMed ID: 11136350
[TBL] [Abstract][Full Text] [Related]
9. Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.
Alenda R; Costa-Frossard L; Alvarez-Lafuente R; Espejo C; Rodríguez-Martín E; de la Maza SS; Villarrubia N; Río J; Domínguez-Mozo MI; Montalban X; Álvarez-Cermeño JC; Villar LM
J Neurol; 2018 Jan; 265(1):24-31. PubMed ID: 29027004
[TBL] [Abstract][Full Text] [Related]
10. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
Chatzimanolis N; Kraus J; Bauer R; Engelhardt B; Bregenzer T; Kuehne BS; Tofighi J; Laske C; Stolz E; Blaes F; Voigt K; Traupe H; Kaps M; Oschmann P
Acta Neurol Scand; 2004 Dec; 110(6):377-85. PubMed ID: 15527450
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Teniente-Serra A; Grau-López L; Mansilla MJ; Fernández-Sanmartín M; Ester Condins A; Ramo-Tello C; Martínez-Cáceres E
Autoimmunity; 2016 Jun; 49(4):219-28. PubMed ID: 26829210
[TBL] [Abstract][Full Text] [Related]
13. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
Genç K; Dona DL; Reder AT
J Clin Invest; 1997 Jun; 99(11):2664-71. PubMed ID: 9169496
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis.
Paź A; Fiszer U; Zaborski J; Korlak J; Członkowski A; Członkowska A
Eur J Neurol; 1999 May; 6(3):347-52. PubMed ID: 10210917
[TBL] [Abstract][Full Text] [Related]
15. IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
García-Merino A; Barcenilla H; Díaz D; Monserrat J; Prieto A; Alvarez-Mon M;
Clin Immunol; 2009 Aug; 132(2):195-202. PubMed ID: 19443275
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
[TBL] [Abstract][Full Text] [Related]
18. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
[TBL] [Abstract][Full Text] [Related]
19. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.
González-Oria MC; Márquez-Coello M; Girón-Ortega JA; Argente J; Moya M; Girón-González JA
J Neuroimmune Pharmacol; 2019 Sep; 14(3):413-422. PubMed ID: 30649665
[TBL] [Abstract][Full Text] [Related]
20. Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neuhaus O; Strasser-Fuchs S; Fazekas F; Kieseier BC; Niederwieser G; Hartung HP; Archelos JJ
Neurology; 2002 Oct; 59(7):990-7. PubMed ID: 12370451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
